These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15310763)

  • 1. Orexins acting at native OX(1) receptor in colon cancer and neuroblastoma cells or at recombinant OX(1) receptor suppress cell growth by inducing apoptosis.
    Rouet-Benzineb P; Rouyer-Fessard C; Jarry A; Avondo V; Pouzet C; Yanagisawa M; Laboisse C; Laburthe M; Voisin T
    J Biol Chem; 2004 Oct; 279(44):45875-86. PubMed ID: 15310763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orexin-induced apoptosis: the key role of the seven-transmembrane domain orexin type 2 receptor.
    Voisin T; Firar AE; Avondo V; Laburthe M
    Endocrinology; 2006 Oct; 147(10):4977-84. PubMed ID: 16857748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orexin A suppresses the growth of rat C6 glioma cells via a caspase-dependent mechanism.
    Biegańska K; Sokołowska P; Jöhren O; Zawilska JB
    J Mol Neurosci; 2012 Nov; 48(3):706-12. PubMed ID: 22588980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The orexin receptor OX(1)R in colon cancer: a promising therapeutic target and a new paradigm in G protein-coupled receptor signalling through ITIMs.
    Laburthe M; Voisin T
    Br J Pharmacol; 2012 Mar; 165(6):1678-1687. PubMed ID: 21627633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors.
    Smart D; Jerman JC; Brough SJ; Neville WA; Jewitt F; Porter RA
    Br J Pharmacol; 2000 Apr; 129(7):1289-91. PubMed ID: 10742282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orexins/hypocretins acting at Gi protein-coupled OX 2 receptors inhibit cyclic AMP synthesis in the primary neuronal cultures.
    Urbańska A; Sokołowska P; Woldan-Tambor A; Biegańska K; Brix B; Jöhren O; Namiecińska M; Zawilska JB
    J Mol Neurosci; 2012 Jan; 46(1):10-7. PubMed ID: 21547533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep.
    Mieda M; Hasegawa E; Kisanuki YY; Sinton CM; Yanagisawa M; Sakurai T
    J Neurosci; 2011 Apr; 31(17):6518-26. PubMed ID: 21525292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual orexin receptor antagonist almorexant induces sleep and decreases orexin-induced locomotion by blocking orexin 2 receptors.
    Mang GM; Dürst T; Bürki H; Imobersteg S; Abramowski D; Schuepbach E; Hoyer D; Fendt M; Gee CE
    Sleep; 2012 Dec; 35(12):1625-35. PubMed ID: 23204605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SK-N-MC cell line expresses an orexin binding site different from recombinant orexin 1-type receptor.
    Wieland HA; Söll RM; Doods HN; Stenkamp D; Hurnaus R; Lämmle B; Beck-Sickinger AG
    Eur J Biochem; 2002 Feb; 269(4):1128-35. PubMed ID: 11856342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arachidonic acid release mediated by OX1 orexin receptors.
    Turunen PM; Ekholm ME; Somerharju P; Kukkonen JP
    Br J Pharmacol; 2010 Jan; 159(1):212-21. PubMed ID: 20002100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an orexin-2 receptor selective agonist, [Ala(11), D-Leu(15)]orexin-B.
    Asahi S; Egashira S; Matsuda M; Iwaasa H; Kanatani A; Ohkubo M; Ihara M; Morishima H
    Bioorg Med Chem Lett; 2003 Jan; 13(1):111-3. PubMed ID: 12467628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocretin/orexin increases the expression of steroidogenic enzymes in human adrenocortical NCI H295R cells.
    Wenzel J; Grabinski N; Knopp CA; Dendorfer A; Ramanjaneya M; Randeva HS; Ehrhart-Bornstein M; Dominiak P; Jöhren O
    Am J Physiol Regul Integr Comp Physiol; 2009 Nov; 297(5):R1601-9. PubMed ID: 19793950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orexin 1 receptor messenger ribonucleic acid expression and stimulation of testosterone secretion by orexin-A in rat testis.
    Barreiro ML; Pineda R; Navarro VM; Lopez M; Suominen JS; Pinilla L; Señaris R; Toppari J; Aguilar E; Diéguez C; Tena-Sempere M
    Endocrinology; 2004 May; 145(5):2297-306. PubMed ID: 14764632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orexin signaling in recombinant neuron-like cells.
    Holmqvist T; Akerman KE; Kukkonen JP
    FEBS Lett; 2002 Aug; 526(1-3):11-4. PubMed ID: 12208495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation.
    Xu TR; Ward RJ; Pediani JD; Milligan G
    J Biol Chem; 2012 Apr; 287(18):14937-49. PubMed ID: 22389503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The physiology and pharmacology of the orexins.
    Smart D; Jerman J
    Pharmacol Ther; 2002; 94(1-2):51-61. PubMed ID: 12191593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of amylase release by Orexin is mediated by Orexin 2 receptor in AR42J cells.
    Harris DM; Go VL; Reeve JR; Wu SV
    Pancreas; 2002 Nov; 25(4):405-10. PubMed ID: 12409837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple phospholipase activation by OX(1) orexin/hypocretin receptors.
    Johansson L; Ekholm ME; Kukkonen JP
    Cell Mol Life Sci; 2008 Jun; 65(12):1948-56. PubMed ID: 18488139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orexins promote survival of rat cortical neurons.
    Sokołowska P; Urbańska A; Namiecińska M; Biegańska K; Zawilska JB
    Neurosci Lett; 2012 Jan; 506(2):303-6. PubMed ID: 22138089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The orexin OX1 receptor activates a novel Ca2+ influx pathway necessary for coupling to phospholipase C.
    Lund PE; Shariatmadari R; Uustare A; Detheux M; Parmentier M; Kukkonen JP; Akerman KE
    J Biol Chem; 2000 Oct; 275(40):30806-12. PubMed ID: 10880509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.